EU Microplastics Restriction: Supplier Documentation for Industrial Chemical Buyers

For European industrial chemical buyers, the EU microplastics restriction should trigger a product-and-use review, not a blanket statement that every polymer-containing material is banned or exempt. Commission Regulation (EU) 2023/2055 added entry 78 for synthetic polymer microparticles to REACH Annex XVII. The restriction concerns defined synthetic polymer microparticles (SPMs), whether on their own or intentionally present in mixtures to confer a sought-after characteristic. Its scope, exclusions, derogations, information duties and transition timing depend on the actual material and supply-chain role.

That distinction is commercially important. A procurement team may be buying a formulation additive, dispersion, powder, polymer-containing processing aid, cleaning product or custom mixture. A familiar trade name cannot establish whether the offered product meets the SPM definition, whether a particular placing-on-market route is restricted, or whether a derogation and related information or reporting obligations are relevant. The responsible legal and regulatory owners must make those conclusions for the specific case. Buyers can make that assessment faster and more defensible by preserving the right evidence before a material is approved or changed.

Start with the regulated product configuration

Entry 78 is technical. The Regulation defines SPMs as polymers that are solid and meet specified particle, concentration and size criteria; it also provides exclusions, including specified naturally occurring, degradable and soluble polymers. ECHA’s restriction information makes clear that the framework is not a shorthand for “contains plastic.” Do not convert a supplier’s generic polymer declaration into a regulatory conclusion without the composition, physical form and use information needed for an accountable assessment.

For an EU microplastics restriction supplier documentation review, create a record for the precise offered item: legal product and commercial name, grade, formulation or composition version, relevant polymer identity, physical form, intended function, concentration where relevant, package, market, customer type and intended industrial use. Identify the entity that will manufacture, import, distribute or use the product in the EEA. Preserve the proposed effective date; a transition date cannot be evaluated correctly if the product and placing-on-market event are unclear.

Use controlled documentation so the material record points to the actual supporting files rather than an unversioned email summary. Link the commercial project to European market support, but keep legal interpretation with the accountable regulatory owner. This separation prevents a sales description, an SDS heading or a purchase order from being treated as the final scope determination.

Ask suppliers targeted questions, not a generic compliance question

“Is this product microplastic compliant?” usually produces an answer too vague to use. Instead, ask the supplier to identify the offered product revision and state what evidence it has considered. Questions may cover the polymer’s identity, whether the supplier considers any polymeric component to meet the entry 78 SPM definition, the component’s intended function, the product’s form, whether the product is supplied on its own or in a mixture, and whether the supplier relies on a stated exclusion, derogation or transition provision. Ask for the document revision, source and limits of the statement.

A buyer should not demand unnecessary confidential formula detail. The objective is a reliable information route: enough evidence for the responsible party to assess the proposed supply, and a method for obtaining additional information when an authority or the customer’s regulatory owner legitimately needs it. The Regulation includes information provisions under which manufacturers, importers and industrial downstream users may need to provide polymer identity and function to competent authorities upon request. It also sets expectations around information for polymers claimed to be excluded because of degradability or solubility. Those are reasons to document a source and escalation path, not reasons to publish sensitive formulation data in an uncontrolled purchasing file.

For a REACH Annex XVII microplastics supplier questionnaire, retain the supplier reply with the product code, composition or formula revision where available, date, supplier legal entity and named contact function. Record unanswered questions and assumptions as open items. A verbal assurance may help start a conversation, but it should not silently close a release gate for a new material or destination.

Keep product performance and regulatory evidence distinct

Supplier qualification still needs technical evidence. A polymer-containing formulation may require assay, viscosity, solids, particle distribution, moisture, impurity profile, packaging compatibility or application testing. None of these measurements alone determine the entry 78 position. Conversely, a regulatory scope statement does not demonstrate that the material meets a coating, cleaning, process or analytical requirement.

Maintain separate, connected tracks. The technical track may use testing and analytical documentation and the intended application context. The regulatory-information track stores the product identity, proposed supply route, supplier evidence, regulatory review owner and conclusion reference. Connecting both tracks through the same approved item and revision avoids a common failure: a formulation change passes technical incoming checks but its documentation package still describes the predecessor formulation.

This discipline is especially useful for custom and private-label work. Where a product is reformulated, repacked or supplied under a different commercial identity, identify which organisation controls the formulation information and who will assess the placing-on-market route. The OEM and custom chemical supply route can help structure the project, but it cannot replace the parties’ own regulatory assessment.

Plan for reporting without assuming it applies

ECHA states that the restriction introduces annual emission reporting for certain derogated uses. Its reporting page says the obligation begins in 2026 for manufacturers and industrial downstream users using SPM pellets, flakes and powders as feedstock in plastic manufacturing at industrial sites, and in 2027 for other relevant industrial users and suppliers of products containing SPMs subject to derogations. Reports are due annually by 31 May for emissions during the preceding calendar year. ECHA also describes preparation in IUCLID and submission through REACH-IT.

These dates are useful planning signals, not a finding that a particular buyer must report. A procurement team should identify the potential reporting owner early and retain the data that owner will need to evaluate the actual role, use and derogation. Do not announce a reporting obligation merely because a material contains a polymer, and do not treat a supplier’s report as proof that another entity has no obligations. Corporate structure, product configuration, use and the relevant legal role matter.

For ECHA microplastics reporting industrial downstream user planning, add a controlled handoff: product and polymer identity; form and use; supplier evidence; proposed site; annual quantity or activity context where the owner requires it; applicable decision reference; and a calendar owner. Keep access restricted to personnel who need it. This makes it possible to reopen the assessment when the product, site or supply route changes.

Build microplastics restriction change control into purchasing

A supplier change can alter more than price or lead time. Trigger review when the product code, grade, formula, polymer source, particle form, concentration range, physical form, intended function, package, site, supplier legal entity, EEA importer, use, customer type or destination changes. A revised SDS date should also prompt a document comparison; it does not, by itself, prove that the entry 78 analysis is unchanged.

The buyer’s change request should state the current and proposed configurations, stock disposition, planned effective date, technical testing needs and regulatory-review owner. Hold routine release until the designated owner records the outcome. If the outcome depends on a missing supplier response, label the material status accurately rather than letting supply urgency convert an open question into an implied approval. Tie released material to batch traceability so the delivered lot, supplier revision and relevant decision can be reconstructed later.

Buyer checklist

• Identify the exact product, polymer-containing component, form, function, use, market and supply-chain role.
• Request product-specific, revision-controlled supplier evidence rather than a generic compliance slogan.
• Keep a regulatory assessment record separate from technical performance qualification.
• Document the source, scope, reviewer and unresolved limitations of each supplier statement.
• Route confidential composition information through an agreed, controlled path.
• Identify a reporting owner only after the actual role, use and applicable derogation have been assessed.
• Use ECHA’s 2026 and 2027 reporting timing as a planning cue, not as an automatic applicability determination.
• Reopen the review when formulation, source, form, use, site, route or market changes.

A practical EU chemical procurement microplastics evidence workflow does not substitute for legal advice. It gives the accountable experts a complete, versioned product record and gives procurement a defensible release gate. For a defined European chemical project, review compliance documentation and request a controlled documentation review with the product, use, pack and destination.